Our value creation model

Our Business

We are an integrated research, development and manufacturing organization providing scientific services from early discovery to commercial supply. We serve a wide range of industrial sectors including pharmaceutical, biotechnology, nutrition, animal health, consumer goods and specialty chemical companies.

We deliver shared value

We actively support ~400 customers worldwide

We invest in the communities where we operate

We deliver returns to shareholders

To be a world-class partner delivering innovative scientific solutions.

World-class infrastructure

Certified to international standards, offering a breadth of facilities and scale

Responsible environment, social and governance

embedded in our operations

Talented resources

Our focus is on attracting, retaining, and nurturing skilled individuals. We ensure a secure work setting for our diverse workforce of 8,146 employees (as of March 31, 2024) including more than 5,656 scientists.

Strategic sourcing Effective collaboration with suppliers

who deliver high quality materials and capital projects:

2,800+ suppliers

Robust business model

Delivering dynamic growth, profitability, returns with good governance

One-stop shop

Discovery, development, and manufacturing services for large and small molecules

Latest technology and training, 24/7 support

Strong project management

Safety first throughout all operations

ESG strategy and targets reported annually

Committed to SBTi

Scientific and operational excellence

Commitment to diversity in the workplace

An agile and personalized learning culture to enable continuous learning and development

Leadership development at every tier through a competency framework and targeted development programs

Strategic succession planning for business-critical roles across the organization, ensuring long-term stability and growth

Integrating data analytics and data-driven decision -making processes to enhance talent management strategies and operational excellence

Sustainable partnerships create a resilient value chain

USD 220 Mn+ annual spend with suppliers, including capital items

Dual-sourcing of critical materials

Investment of Rs 50 Bn (USD 613 Mn) in infrastructure and facilities

Strong track record of growth with good demand visibility for the future

Operating EBITDA margins maintained around 29%

Robust risk management process to address changing business environment

End-to-end scientific solutions across multiple modalities and multiple industries

Strong track record with major regulators

Availability of skills and technology not available in-house for clients (especially with emerging biotech)

Continuous improvement, reliability and ability to deliver at scale

Understanding of environmental impact, ethical standards and governance

A great place to work

Our collective experience from hundreds of projects enriches client outcomes

Frequent interactions with clients and the ability to form versatile teams leveraging a wide range of skills available in-house

A commitment to equal opportunities: 26% of our permanent roles are filled by women, with 12% women in leadership positions; we also ensure inclusivity for differently abled employees

Ecosystem of suppliers

Niche sourcing skills to manage complex supply chain

Proactive partnerships to enforce high standards of business ethics and environmental management

Industry leadership through sustainable growth

Experienced leadership team

Strong governance

Strategy to drive investment and growth

Absolute focus on efficiency and compliance

Track record of reliable delivery

A partner for the long term

Timely project delivery to clients

Innovation captured in 400+ patents over thirty years

Problem-solving on an industrial scale

Opportunities to engage in cutting-edge, global science without the need to relocate from India

Resilient supply chain

Development of supplier capabilities in business ethics and environmental standards

On time delivery to clients

Availability of key capabilities through experienced suppliers and consultants

Revenue from operations growth of 9% for FY24

Earnings per share (basic) of Rs 12.71 in FY24

Total market cap increase of 350% since listing (to March 2024)